title: Contraceptive potential of an antiprogestin ZK 98.734: reversal of ZK 98.734--induced blockade of folliculogenesis with FSH and LH and their differential effects in bonnet monkeys.
abstract: Studies were undertaken in adult bonnet monkeys to investigate whether treatment with an antiprogestin ZK 98.734 at weekly intervals, starting from day one of menstrual cycle, could arrest ovulation and also to determine if ZK 98.734 induced blockade of ovulation could be reversed with gonadotropins. Adult animals have ovulatory menstrual cycles of normal duration were treated at weekly intervals with ZK 98.734 (25 mg/dose, sc, oil base) for 10 consecutive weeks and its effects on serum levels of estradiol, bioactive LH and progesterone, and endometrial histology were investigated. Following treatment with the antiprogestin they were treated with hMG or hFSH alone. Ovulation was blocked during treatment period in all the animals (n = 14). Typical follicular phase rise in estradiol levels was inhibited, mid cycle surge in the levels of bioactive LH was abolished and serum progesterone levels remained below 1 ng/ml throughout the treatment period. However, prolonged treatment had no significant effect on the basal levels of estradiol which were around 50 pg/ml. ZK 98.734 also had no significant effect on cortisol levels. In animals (n = 4) followed for recovery after the last dose, the treatment cycle length was increased to 117.8 + 6.8 days. In three animals the treatment cycles were anovulatory, whereas in one delayed ovulation with luteal insufficiency was observed. The endometrium had become atrophic. Treatment with hMG (Pergonal: 35 I.U. hLH and 35 I.U. hFSH) or hFSH (Metrodin, 35 I.U.) for 7 consecutive days initiated folliculogenesis and the animals ovulated either spontaneously or after a single im injection of hCG (100 I.U.) on day 8 in ZK 98.734 treated animals.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Institute for Research in Reproduction (ICMR), Bombay, India.
authors.forename: C P
authors.initials: CP
authors.lastname: Puri
authors.forename: R R
authors.initials: RR
authors.lastname: Katkam
authors.forename: A D
authors.initials: AD
authors.lastname: Vadigoppula
authors.forename: K
authors.initials: K
authors.lastname: Gopalakrishnan
authors.forename: W A
authors.initials: WA
authors.lastname: Elger
authors.forename: F R
authors.initials: FR
authors.lastname: Billimoria
authors.forename: R K
authors.initials: RK
authors.lastname: Patil
mesh_terms: D000818:Animals; D003271:Contraceptive Agents, Female / Q000494:pharmacology*; D004958:Estradiol / Q000097:blood; D004963:Estrenes / Q000494:pharmacology*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000494:pharmacology*; D007986:Luteinizing Hormone / Q000097:blood / Q000494:pharmacology*; D008255:Macaca radiata; D008597:Menstrual Cycle / Q000187:drug effects*; D006080:Ovarian Follicle / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D011374:Progesterone / Q000097:blood; D011372:Progestins / Q000037:antagonists & inhibitors*
chemical_list: D003271:Contraceptive Agents, Female; D004963:Estrenes; D011372:Progestins; C048260:lilopristone; D011374:Progesterone; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone